• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑纤溶酶增强淀粉样前体蛋白(APP)的α-裂解及β淀粉样蛋白(Aβ)的降解,且在阿尔茨海默病大脑中减少。

Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.

作者信息

Ledesma M D, Da Silva J S, Crassaerts K, Delacourte A, De Strooper B, Dotti C G

机构信息

Cell Biology and Biophysics Program, EMBL, Heidelberg, Germany.

出版信息

EMBO Rep. 2000 Dec;1(6):530-5. doi: 10.1093/embo-reports/kvd107.

DOI:10.1093/embo-reports/kvd107
PMID:11263499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1083779/
Abstract

The proteolytic processing of amyloid precursor protein (APP) has been linked to sphingolipid-cholesterol microdomains (rafts). However, the raft proteases that may be involved in APP cleavage have not yet been identified. In this work we present evidence that the protease plasmin is restricted to rafts of cultured hippocampal neurons. We also show that plasmin increases the processing of human APP preferentially at the alpha-cleavage site, and efficiently degrades secreted amyloidogenic and non-amyloidogenic APP fragments. These results suggest that brain plasmin plays a preventive role in APP amyloidogenesis. Consistently, we show that brain tissue from Alzheimer's disease patients contains reduced levels of plasmin, implying that plasmin downregulation may cause amyloid plaque deposition accompanying sporadic Alzheimer's disease.

摘要

淀粉样前体蛋白(APP)的蛋白水解加工与鞘脂 - 胆固醇微结构域(脂筏)有关。然而,可能参与APP切割的脂筏蛋白酶尚未被鉴定出来。在这项研究中,我们提供证据表明蛋白酶纤溶酶局限于培养的海马神经元的脂筏中。我们还表明,纤溶酶优先增加人APP在α-切割位点的加工,并有效降解分泌的淀粉样生成和非淀粉样生成的APP片段。这些结果表明,脑纤溶酶在APP淀粉样变过程中起预防作用。一致地,我们表明阿尔茨海默病患者的脑组织中纤溶酶水平降低,这意味着纤溶酶下调可能导致散发性阿尔茨海默病伴随的淀粉样斑块沉积。

相似文献

1
Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.脑纤溶酶增强淀粉样前体蛋白(APP)的α-裂解及β淀粉样蛋白(Aβ)的降解,且在阿尔茨海默病大脑中减少。
EMBO Rep. 2000 Dec;1(6):530-5. doi: 10.1093/embo-reports/kvd107.
2
Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.衰老和淀粉样β蛋白沉积对阿尔茨海默病Tg2576小鼠模型中纤溶酶原激活剂和纤溶酶原激活剂抑制剂-1的影响。
Brain Res. 2015 Feb 9;1597:159-67. doi: 10.1016/j.brainres.2014.11.042. Epub 2014 Nov 29.
3
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains.淀粉样蛋白筏紊乱导致阿尔茨海默病大脑中纤溶酶活性降低。
EMBO Rep. 2003 Dec;4(12):1190-6. doi: 10.1038/sj.embor.7400021. Epub 2003 Nov 14.
4
The role of seladin-1/DHCR24 in cholesterol biosynthesis, APP processing and Abeta generation in vivo.硒代蛋氨酸-1/DHCR24在体内胆固醇生物合成、淀粉样前体蛋白加工及β-淀粉样蛋白生成中的作用。
EMBO J. 2006 Jan 25;25(2):432-43. doi: 10.1038/sj.emboj.7600938. Epub 2006 Jan 12.
5
Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.β淀粉样蛋白促进神经元脂筏中电压依赖性阴离子通道1(VDAC1)的去磷酸化。与阿尔茨海默病神经毒性机制的相关性。
Neuroscience. 2014 Oct 10;278:354-66. doi: 10.1016/j.neuroscience.2014.07.079. Epub 2014 Aug 26.
6
The degradation of Abeta(25-35) by the serine protease plasmin is inhibited by aluminium.
J Alzheimers Dis. 2002 Oct;4(5):357-67. doi: 10.3233/jad-2002-4503.
7
Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts.β-分泌酶(Asp2)分隔至低浮力密度、非小窝脂质筏中。
Curr Biol. 2001 Aug 21;11(16):1288-93. doi: 10.1016/s0960-9822(01)00394-3.
8
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.阿尔茨海默病β-淀粉样前体蛋白的淀粉样生成过程依赖于脂筏。
J Cell Biol. 2003 Jan 6;160(1):113-23. doi: 10.1083/jcb.200207113.
9
The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system.脑胆固醇在阿尔茨海默病中的矛盾作用:来自脑纤溶酶原系统的启示。
Biochem Soc Symp. 2005(72):129-38. doi: 10.1042/bss0720129.
10
α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction.α(2A)肾上腺素能受体通过破坏APP-SorLA相互作用促进淀粉样蛋白生成。
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17296-301. doi: 10.1073/pnas.1409513111. Epub 2014 Nov 17.

引用本文的文献

1
Brain and CSF Alzheimer's Biomarkers Are Associated with SERPINE1 Gene Expression.大脑和脑脊液中的阿尔茨海默病生物标志物与丝氨酸蛋白酶抑制剂E1(SERPINE1)基因表达相关。
Genes (Basel). 2025 Jul 12;16(7):818. doi: 10.3390/genes16070818.
2
The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective.组织型纤溶酶原激活物/神经丝氨酸蛋白酶抑制剂轴在阿尔茨海默病中的可能作用:新视角。
Acta Neurol Belg. 2024 Apr;124(2):377-388. doi: 10.1007/s13760-023-02403-x. Epub 2023 Nov 2.
3
Advances in Amyloid-β Clearance in the Brain and Periphery: Implications for Neurodegenerative Diseases.大脑和外周淀粉样β清除的进展:对神经退行性疾病的影响
Exp Neurobiol. 2023 Aug 31;32(4):216-246. doi: 10.5607/en23014.
4
Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach.氨甲环酸在脑淀粉样血管病小鼠模型中的应用:为新型中风治疗方法奠定基础。
Res Pract Thromb Haemost. 2023 Aug 9;7(6):102166. doi: 10.1016/j.rpth.2023.102166. eCollection 2023 Aug.
5
Emerging Nanotechnology for the Treatment of Alzheimer's Disease.新兴纳米技术治疗老年痴呆症。
CNS Neurol Disord Drug Targets. 2024;23(6):687-696. doi: 10.2174/1871527322666230501232815.
6
Vascular Dysfunction in Alzheimer's Disease: Alterations in the Plasma Contact and Fibrinolytic Systems.阿尔茨海默病中的血管功能障碍:血浆接触和纤维蛋白溶解系统的改变。
Int J Mol Sci. 2023 Apr 11;24(8):7046. doi: 10.3390/ijms24087046.
7
Alzheimer's Disease Severity Is Associated with an Imbalance in Serum Levels of Enzymes Regulating Plasmin Synthesis.阿尔茨海默病的严重程度与调节纤溶酶合成的血清酶水平失衡有关。
Pharmaceuticals (Basel). 2022 Aug 29;15(9):1074. doi: 10.3390/ph15091074.
8
Plasma Levels of Tissue-Type Plasminogen Activator (tPA) in Normal Aging and Alzheimer's Disease: Links With Cognition, Brain Structure, Brain Function and Amyloid Burden.正常衰老和阿尔茨海默病中组织型纤溶酶原激活物(tPA)的血浆水平:与认知、脑结构、脑功能及淀粉样蛋白负荷的关联
Front Aging Neurosci. 2022 Jun 7;14:871214. doi: 10.3389/fnagi.2022.871214. eCollection 2022.
9
Review of evidence implicating the plasminogen activator system in blood-brain barrier dysfunction associated with Alzheimer's disease.纤溶酶原激活物系统与阿尔茨海默病相关的血脑屏障功能障碍的证据综述。
Ageing Neurodegener Dis. 2022;2. doi: 10.20517/and.2022.05. Epub 2022 Jan 29.
10
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease.组织型纤溶酶原激活物在中枢神经系统生理学和病理学中的作用:从突触可塑性到阿尔茨海默病。
Semin Thromb Hemost. 2022 Apr;48(3):288-300. doi: 10.1055/s-0041-1740265. Epub 2021 Dec 23.

本文引用的文献

1
The plasmin system is induced by and degrades amyloid-beta aggregates.纤溶酶系统由β淀粉样蛋白聚集体诱导产生并使其降解。
J Neurosci. 2000 Jun 1;20(11):3937-46. doi: 10.1523/JNEUROSCI.20-11-03937.2000.
2
Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients.阿尔茨海默病患者脑脊液中α-和β-分泌酶切割的淀粉样前体蛋白水平。
Neurosci Lett. 2000 Jan 14;278(3):169-72. doi: 10.1016/s0304-3940(99)00929-5.
3
Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein.膜锚定金属蛋白酶MDC9具有负责加工淀粉样前体蛋白的α-分泌酶活性。
Biochem J. 1999 Oct 15;343 Pt 2(Pt 2):371-5.
4
Reduced cerebrospinal fluid levels of alpha-secretase-cleaved amyloid precursor protein in aged rats: correlation with spatial memory deficits.老年大鼠脑脊液中α-分泌酶切割的淀粉样前体蛋白水平降低:与空间记忆缺陷的相关性。
Neuroscience. 1999;93(4):1409-20. doi: 10.1016/s0306-4522(99)00244-4.
5
Cellular mechanisms of beta-amyloid production and secretion.β-淀粉样蛋白产生与分泌的细胞机制。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11049-53. doi: 10.1073/pnas.96.20.11049.
6
Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity.β-淀粉样蛋白的纤溶酶裂解:二级结构的改变及对组织纤溶酶原激活物活性的刺激
Biochemistry. 1999 Aug 31;38(35):11570-6. doi: 10.1021/bi990610f.
7
Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells.阿尔茨海默病淀粉样前体蛋白被α-分泌酶切割发生在神经元细胞表面。
Biochemistry. 1999 Jul 27;38(30):9728-34. doi: 10.1021/bi9906827.
8
Translating cell biology into therapeutic advances in Alzheimer's disease.将细胞生物学转化为阿尔茨海默病的治疗进展。
Nature. 1999 Jun 24;399(6738 Suppl):A23-31. doi: 10.1038/399a023.
9
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.一种去整合素金属蛋白酶对阿尔茨海默病淀粉样前体蛋白的组成性和调节性α-分泌酶切割
Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3922-7. doi: 10.1073/pnas.96.7.3922.
10
The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus.肝细胞生长因子/分散因子、其受体c-met及其激活剂之一组织型纤溶酶原激活剂的mRNA表达在发育中和成年的大脑皮层及海马体中呈现出一种系统性关系。
Brain Res. 1999 Mar 13;821(2):356-67. doi: 10.1016/s0006-8993(99)01115-4.